Description

Macrocef 1000 mg/1000 mg Powder for Solution for Injections Vial №1

Ingredients:

Macrocef 1000 mg/1000 mg powder for solution for injections contains a combination of Ceftriaxone Sodium and Sulbactam Sodium as active ingredients.

Dosage:

Macrocef 1000 mg/1000 mg is administered as directed by a healthcare professional. The dosage may vary depending on the condition being treated. It is usually given intravenously or intramuscularly.

Indications:

Macrocef 1000 mg/1000 mg is indicated for the treatment of severe bacterial infections caused by susceptible microorganisms. It is commonly used in the management of respiratory tract infections, skin and soft tissue infections, urinary tract infections, and more.

Contraindications:

Macrocef 1000 mg/1000 mg is contraindicated in patients with known hypersensitivity to cephalosporins or beta-lactam antibiotics. It should be used with caution in patients with a history of gastrointestinal diseases.

Directions:

The solution should be prepared according to the manufacturer’s instructions. It is important to follow proper aseptic techniques during reconstitution. The reconstituted solution should be clear and free from particles before administration.

Scientific Evidence:

Studies have shown the efficacy of Ceftriaxone in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of Sulbactam in enhancing the activity of beta-lactam antibiotics against resistant bacteria.

Additional Information:

It is important to complete the full course of treatment with Macrocef 1000 mg/1000 mg as prescribed by the healthcare provider, even if symptoms improve before the course is finished. This helps prevent the development of antibiotic resistance.

Pharmacologically, Macrocef 1000 mg/1000 mg exerts its effects by inhibiting bacterial cell wall synthesis, leading to cell death. The combination of Ceftriaxone and Sulbactam offers a broad spectrum of activity against various pathogens.

Clinical trials have shown that Macrocef 1000 mg/1000 mg is well-tolerated and effective in the treatment of severe infections. Comparative studies have highlighted its superiority in certain cases over other antibiotic combinations, making it a valuable option in clinical practice.